Neurologic Bone Marrow Derived Stem Cell Treatment Study

This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/

Full record on ClinicalTrials.gov (NCT ID NCT02795052).

Age range: ≥ 18 · Sex: All · Healthy volunteers: Requires diagnosis

Phase

Phase None

Study type

Interventional

Masking

Open label

Intervention model

Single group assignment

Primary purpose

Treatment

Enrollment target

500 participants

Started

June 2016

Estimated completion

July 2028

3 sites currently enrolling. Representative sites shown below; full site list on ClinicalTrials.gov.